Scripps researchers add power to antibiotic vancomycin, giving it a third mechanism to fight superbugs
The emergence of antibiotic-resistant bacteria is a major worldwide concern for healthcare professionals worldwide, who in some cases, have been rendered powerless to help patients survive superbug infections that have out-evolved existing drugs. Progress has slowed on creating new antibiotics over several decades as many companies calculated their return on investment for developing one won’t be sufficient, at least without special incentives. According to the World Health Organization, “Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.